References
1. Shawon MS, Perret JL, Senaratna CV, Lodge C, Hamilton GS, Dharmage
SC. Current evidence on prevalence and clinical outcomes of co-morbid
obstructive sleep apnea and chronic obstructive pulmonary disease: A
systematic review. Sleep Med Rev. 2017;32:58-68.
2. Kong DL, Qin Z, Shen H, Jin HY, Wang W, Wang ZF. Association of
Obstructive Sleep Apnea with Asthma: A Meta-Analysis. Sci Rep.2017;7(1):4088.
3. Teodorescu M, Barnet JH, Hagen EW, Palta M, Young TB, Peppard PE.
Association between asthma and risk of developing obstructive sleep
apnea. JAMA. 2015;313(2):156-164.
4. Soler X, Gaio E, Powell FL, et al. High Prevalence of Obstructive
Sleep Apnea in Patients with Moderate to Severe Chronic Obstructive
Pulmonary Disease. Ann Am Thorac Soc. 2015;12(8):1219-1225.
5. Perin C, Fagondes SC, Casarotto FC, Pinotti AF, Menna Barreto SS,
Dalcin Pde T. Sleep findings and predictors of sleep desaturation in
adult cystic fibrosis patients. Sleep Breath.2012;16(4):1041-1048.
6. Milross MA, Piper AJ, Dobbin CJ, Bye PT, Grunstein RR. Sleep
disordered breathing in cystic fibrosis. Sleep Med Rev.2004;8(4):295-308.
7. McNicholas WT, Hansson D, Schiza S, Grote L. Sleep in chronic
respiratory disease: COPD and hypoventilation disorders. Eur
Respir Rev. 2019;28(153).
8. American Academy of Sleep Medicine. International Classification of
Sleep Disorders, 3rd Edition. Darien, IL: American Academy of Sleep
Medicine, 2014.
9. Mohammadieh A, Sutherland K, Cistulli PA. Sleep disordered breathing:
management update. Intern Med J. 2017;47(11):1241-1247.
10. Akerstedt T, Ghilotti F, Grotta A, Bellavia A, Lagerros YT, Bellocco
R. Sleep duration, mortality and the influence of age. Eur J
Epidemiol. 2017;32(10):881-891.
11. Naqvi SK, Sotelo C, Murry L, Simakajornboon N. Sleep architecture in
children and adolescents with cystic fibrosis and the association with
severity of lung disease. Sleep Breath. 2008;12(1):77-83.
12. Bradley S, Solin P, Wilson J, Johns D, Walters EH, Naughton MT.
Hypoxemia and hypercapnia during exercise and sleep in patients with
cystic fibrosis. Chest. 1999;116(3):647-654.
13. Spicuzza L, Sciuto C, Leonardi S, La Rosa M. Early occurrence of
obstructive sleep apnea in infants and children with cystic fibrosis.Arch Pediatr Adolesc Med. 2012;166(12):1165-1169.
14. Bandla H, Splaingard M. Sleep problems in children with common
medical disorders. Pediatr Clin North Am. 2004;51(1):203-227,
viii.
15. Regard L, Lafoeste H, Martin C, Chassagnon G, Burgel PR. [Ageing
with cystic fibrosis: Classical and emerging comorbidities in adults
with cystic fibrosis]. Rev Pneumol Clin. 2018;74(5):279-291.
16. Litvin M, Yoon JC, Leey Casella J, Blackman SM, Brennan AL. Energy
balance and obesity in individuals with cystic fibrosis. J Cyst
Fibros. 2019;18 Suppl 2:S38-S47.
17. Harindhanavudhi T, Wang Q, Dunitz J, Moran A, Moheet A. Prevalence
and factors associated with overweight and obesity in adults with cystic
fibrosis: A single-center analysis. J Cyst Fibros.2020;19(1):139-145.
18. Hanna RM, Weiner DJ. Overweight and obesity in patients with cystic
fibrosis: a center-based analysis. Pediatr Pulmonol.2015;50(1):35-41.
19. Young T, Palta M, Dempsey J, Peppard PE, Nieto FJ, Hla KM. Burden of
sleep apnea: rationale, design, and major findings of the Wisconsin
Sleep Cohort study. WMJ. 2009;108(5):246-249.
20. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal
study of moderate weight change and sleep-disordered breathing.JAMA. 2000;284(23):3015-3021.
21. Sosnay PR, White TB, Farrell PM, et al. Diagnosis of Cystic Fibrosis
in Nonscreened Populations. J Pediatr. 2017;181S:S52-S57 e52.
22. Valham F, Mooe T, Rabben T, Stenlund H, Wiklund U, Franklin KA.
Increased risk of stroke in patients with coronary artery disease and
sleep apnea: a 10-year follow-up. Circulation.2008;118(9):955-960.
23. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered
breathing, sleep apnea, and hypertension in a large community-based
study. Sleep Heart Health Study. JAMA. 2000;283(14):1829-1836.
24. Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U.
Sleep-disordered breathing and coronary artery disease: long-term
prognosis. Am J Respir Crit Care Med. 2001;164(10 Pt
1):1910-1913.
25. Peltier AC, Consens FB, Sheikh K, Wang L, Song Y, Russell JW.
Autonomic dysfunction in obstructive sleep apnea is associated with
impaired glucose regulation. Sleep Med. 2007;8(2):149-155.
26. Nap-van der Vlist MM, Burghard M, Hulzebos HJ, et al. Prevalence of
severe fatigue among adults with cystic fibrosis: A single center study.J Cyst Fibros. 2018;17(3):368-374.
27. Piper AJ. Sleep and Breathing in Cystic Fibrosis. Totowa, NJ:
Humana Press; 2012.
28. Marcus CL, Brooks LJ, Draper KA, et al. Diagnosis and management of
childhood obstructive sleep apnea syndrome. Pediatrics.2012;130(3):e714-755.
29. Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical Practice
Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An
American Academy of Sleep Medicine Clinical Practice Guideline. J
Clin Sleep Med. 2017;13(3):479-504.
30. Berry RB, Brooks R, Gamaldo C, et al. AASM Scoring Manual Updates
for 2017 (Version 2.4). J Clin Sleep Med. 2017;13(5):665-666.
31. Douglas NJ, White DP, Pickett CK, Weil JV, Zwillich CW. Respiration
during sleep in normal man. Thorax. 1982;37(11):840-844.
32. White JE, Drinnan MJ, Smithson AJ, Griffiths CJ, Gibson GJ.
Respiratory muscle activity during rapid eye movement (REM) sleep in
patients with chronic obstructive pulmonary disease. Thorax.1995;50(4):376-382.
33. Kirk V, Baughn J, D’Andrea L, et al. American Academy of Sleep
Medicine Position Paper for the Use of a Home Sleep Apnea Test for the
Diagnosis of OSA in Children. J Clin Sleep Med.2017;13(10):1199-1203.
34. Reiter J, Gileles-Hillel A, Cohen-Cymberknoh M, et al. Sleep
disorders in cystic fibrosis: A systematic review and meta-analysis.Sleep Med Rev. 2020;51:101279.
35. Schidlow DV, Taussig LM, Knowles MR. Cystic Fibrosis Foundation
consensus conference report on pulmonary complications of cystic
fibrosis. Pediatr Pulmonol. 1993;15(3):187-198.
36. de Castro-Silva C, de Bruin VM, Cavalcante AG, Bittencourt LR, de
Bruin PF. Nocturnal hypoxia and sleep disturbances in cystic fibrosis.Pediatr Pulmonol. 2009;44(11):1143-1150.
37. Fauroux B, Pepin JL, Boelle PY, et al. Sleep quality and nocturnal
hypoxaemia and hypercapnia in children and young adults with cystic
fibrosis. Arch Dis Child. 2012;97(11):960-966.
38. Frangolias DD, Wilcox PG. Predictability of oxygen desaturation
during sleep in patients with cystic fibrosis : clinical, spirometric,
and exercise parameters. Chest. 2001;119(2):434-441.
39. Tabeling C, Yu H, Wang L, et al. CFTR and sphingolipids mediate
hypoxic pulmonary vasoconstriction. Proc Natl Acad Sci U S A.2015;112(13):E1614-1623.
40. Macrea MM, Owens RL, Martin T, Smith D, Oursler KK, Malhotra A. The
effect of isolated nocturnal oxygen desaturations on serum hs-CRP and
IL-6 in patients with chronic obstructive pulmonary disease. Clin
Respir J. 2019;13(2):120-124.
41. Isaiah A, Daher A, Sharma PB, Naqvi K, Mitchell RB. Predictors of
sleep hypoxemia in children with cystic fibrosis. Pediatr
Pulmonol. 2019;54(3):273-279.
42. Gomez Punter RM, Giron Moreno RM, Vazquez Espinosa E, et al.
Desaturations During 6-Minute Walk Test and Predicting Nocturnal
Desaturations in Adult Subjects With Cystic Fibrosis. Respir
Care. 2019;64(1):48-54.
43. Allen MB, Mellon AF, Simmonds EJ, Page RL, Littlewood JM. Changes in
nocturnal oximetry after treatment of exacerbations in cystic fibrosis.Arch Dis Child. 1993;69(2):197-201.
44. Salvatore D, D’Andria M. Effects of salmeterol on arterial
oxyhemoglobin saturations in patients with cystic fibrosis.Pediatr Pulmonol. 2002;34(1):11-15.
45. Gozal D. Nocturnal ventilatory support in patients with cystic
fibrosis: comparison with supplemental oxygen. Eur Respir J.1997;10(9):1999-2003.
46. Elphick HE, Mallory G. Oxygen therapy for cystic fibrosis.Cochrane Database Syst Rev. 2013(7):CD003884.
47. Ramos RT, Salles C, Gregorio PB, et al. Evaluation of the upper
airway in children and adolescents with cystic fibrosis and obstructive
sleep apnea syndrome. Int J Pediatr Otorhinolaryngol.2009;73(12):1780-1785.
48. Villa MP, Pagani J, Lucidi V, Palamides S, Ronchetti R. Nocturnal
oximetry in infants with cystic fibrosis. Arch Dis Child.2001;84(1):50-54.
49. Jiang RS, Liang KL, Hsin CH, Su MC. The impact of chronic
rhinosinusitis on sleep-disordered breathing. Rhinology.2016;54(1):75-79.
50. Alt JA, DeConde AS, Mace JC, Steele TO, Orlandi RR, Smith TL.
Quality of Life in Patients With Chronic Rhinosinusitis and Sleep
Dysfunction Undergoing Endoscopic Sinus Surgery: A Pilot Investigation
of Comorbid Obstructive Sleep Apnea. JAMA Otolaryngol Head Neck
Surg. 2015;141(10):873-881.
51. Mahdavinia M, Schleimer RP, Keshavarzian A. Sleep disruption in
chronic rhinosinusitis. Expert Rev Anti Infect Ther.2017;15(5):457-465.
52. Mahdavinia M, Hui JW, Zitun M, et al. Patients with chronic
rhinosinusitis and obstructive sleep apnea have increased paroxysmal
limb movement. Am J Rhinol Allergy. 2018;32(2):94-97.
53. Alt JA, Smith TL. Chronic rhinosinusitis and sleep: a contemporary
review. Int Forum Allergy Rhinol. 2013;3(11):941-949.
54. Henderson RC, Specter BB. Kyphosis and fractures in children and
young adults with cystic fibrosis. J Pediatr.1994;125(2):208-212.
55. Troosters T, Langer D, Vrijsen B, et al. Skeletal muscle weakness,
exercise tolerance and physical activity in adults with cystic fibrosis.Eur Respir J. 2009;33(1):99-106.
56. Shook JE, Watkins WD, Camporesi EM. Differential roles of opioid
receptors in respiration, respiratory disease, and opiate-induced
respiratory depression. Am Rev Respir Dis. 1990;142(4):895-909.
57. Milross MA, Piper AJ, Dwyer TJ, et al. Non-invasive ventilation
versus oxygen therapy in cystic fibrosis: A 12-month randomized trial.Respirology. 2019;24(12):1191-1197.
58. de Felicio CM, da Silva Dias FV, Trawitzki LVV. Obstructive sleep
apnea: focus on myofunctional therapy. Nat Sci Sleep.2018;10:271-286.
59. Fleury Curado T, Oliven A, Sennes LU, Polotsky VY, Eisele D,
Schwartz AR. Neurostimulation Treatment of OSA. Chest.2018;154(6):1435-1447.
60. Sarkissian L, Kitipornchai L, Cistulli P, Mackay SG. An update on
the current management of adult obstructive sleep apnoea. Aust J
Gen Pract. 2019;48(4):182-186.
61. Kuhle S, Urschitz MS. Anti-inflammatory medications for obstructive
sleep apnea in children. Cochrane Database Syst Rev.2011(1):CD007074.
62. Smith DF, Sarber KM, Spiceland CP, Ishman SL, Augelli DM, Romaker
AM. Effects of Medical Therapy on Mild Obstructive Sleep Apnea in Adult
Patients. J Clin Sleep Med. 2019;15(7):979-983.
63. Zinman R, Corey M, Coates AL, et al. Nocturnal home oxygen in the
treatment of hypoxemic cystic fibrosis patients. J Pediatr.1989;114(3):368-377.
64. Young AC, Wilson JW, Kotsimbos TC, Naughton MT. Randomised placebo
controlled trial of non-invasive ventilation for hypercapnia in cystic
fibrosis. Thorax. 2008;63(1):72-77.
65. Moran F, Bradley JM, Piper AJ. Non-invasive ventilation for cystic
fibrosis. Cochrane Database Syst Rev. 2017;2:CD002769.
66. Stanford G, Parrott H, Bilton D, Agent P. Positive
pressure–analysing the effect of the addition of non-invasive
ventilation (NIV) to home airway clearance techniques (ACT) in adult
cystic fibrosis (CF) patients. Physiother Theory Pract.2015;31(4):270-274.
67. Rodriguez Hortal MC, Nygren-Bonnier M, Hjelte L. Non-invasive
Ventilation as Airway Clearance Technique in Cystic Fibrosis.Physiother Res Int. 2017;22(3).
68. Valipour A, Makker HK, Hardy R, Emegbo S, Toma T, Spiro SG.
Symptomatic gastroesophageal reflux in subjects with a breathing sleep
disorder. Chest. 2002;121(6):1748-1753.
69. Irwin MR. Why sleep is important for health: a psychoneuroimmunology
perspective. Annu Rev Psychol. 2015;66:143-172.
70. Park H, Tsai KM, Dahl RE, et al. Sleep and Inflammation During
Adolescence. Psychosom Med. 2016;78(6):677-685.
71. Fernandez-Mendoza J, Baker JH, Vgontzas AN, Gaines J, Liao D, Bixler
EO. Insomnia symptoms with objective short sleep duration are associated
with systemic inflammation in adolescents. Brain Behav Immun.2017;61:110-116.
72. Kong AP, Wing YK, Choi KC, et al. Associations of sleep duration
with obesity and serum lipid profile in children and adolescents.Sleep Med. 2011;12(7):659-665.
73. Bonuck K, Chervin RD, Howe LD. Sleep-disordered breathing, sleep
duration, and childhood overweight: a longitudinal cohort study. J
Pediatr. 2015;166(3):632-639.
74. Koren D, Gozal D, Philby MF, Bhattacharjee R, Kheirandish-Gozal L.
Impact of obstructive sleep apnoea on insulin resistance in nonobese and
obese children. Eur Respir J. 2016;47(4):1152-1161.
75. Rudnicka AR, Nightingale CM, Donin AS, et al. Sleep Duration and
Risk of Type 2 Diabetes. Pediatrics. 2017;140(3).
76. Voynow JA MM, Kelly A, Scanlin TF. Cystic Fibrosis. Vol
Chapter 50, Volume 1. 5th Edition ed: McGraw Hill; 2015.
The authors thank Dr. Thomas Scanlin M.D. and Dr. Nisha Aurora M.D. for
their review of the paper and valuable suggestions. The authors also
thank the Cystic Fibrosis Foundation for the grant support of the
Rutgers-Robert Wood Johnson Medical School pediatric and adult Cystic
Fibrosis programs (CC 154).